Drug Database
CA

calcium carbonate (Cimascal / Cimascal D Forte)

✓ Approved

CPEX Pharmaceuticals, Inc. · VDR

什么是 calcium carbonate?

calcium carbonate 是一种治疗药物,由CPEX Pharmaceuticals, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Cimascal, Cimascal D Forte
公司CPEX Pharmaceuticals, Inc.
分子靶点VDR
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

calcium carbonate 作用于 1 个分子靶点:

VDRvitamin D receptor (NR1I1, PPP1R163)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

calcium carbonate 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

相关研究文献

PubMedScientific reports2026-06-13

Physico-mechanical and chemical performance of Portland cement modified with eggshell powder for sustainable construction.

Sanusi Abdulganiyu A, Ndububa Emmanuel Eberechukwu EE, Adeleke Adekunle Akanni AA, Obianyo Ifeyinwa Ijeoma II et al.

Cement is one of the most used materials in the construction industry. Its production contributes about 8% to the global emissions. This study explores the use of eggshell powder (ESP) that contains over 80% calcium carbonate (CaCO3) as a partial substitute for ordinary Portland cement (OPC), such as Types B and D, to substitute limestone within the cement matrix. The physical (consistency and setting time), compressive strength, and chemical (Scanning Electron Microscope with Energy Dispersive Spectroscopy, (SEM-EDS), and X-ray Diffraction (XRD), X-ray fluorescence (XRF)) properties were evaluated against British, Indian, and established standards in the literature. The results showed that cement consistency (31-35%) and setting times were within acceptable limits according to BS EN 197-1 (initial ≥ 60 min) and IS 8112 (initial ≥ 30 min, final ≤ 600 min). The mechanical strength of the samples exceeded the required strength (42.5 N/mm2) recommended by the British Standards, except for samples B10N and D10N, which showed strength reductions of 8.4% and 12.3%, respectively. The SEM-EDS and XRD analyses confirmed a high CaCO3 content in the samples. The study suggests that incorporating ESP into OPC should not exceed 5% by weight, as higher proportions could negatively impact the cement's physical and strength properties. This approach will promote environmental sustainability by using agro-waste while ensuring the cement remains suitable for construction.

PMID 42286071
阅读全文 →
PubMedCarbohydrate polymers2026-06-13

The rheological behavior, particle properties and supramolecular structure of low acyl gellan gum fluid gels: impact of the calcium concentration before fluid gel formation.

D'Oria Gabriele G, Zhu Yanshen Y, Limbach Hans Joerg HJ, Hartmann Christoph C et al.

Fluid gels are jammed microgel suspensions obtained by shearing a gelling hydrocolloid during its sol-gel transition. This study focused on calcium-induced low acyl gellan gum (LAGG) fluid gels and investigated the impact of calcium concentration before fluid gel formation on the resulting rheological behavior, fluid gel particle properties, and supramolecular structure. The elasticity and yield stress of fluid gels and quiescently cooled gels reached a maximum when the calcium concentration was increased from 0.78 to (approx.) 30 mmol/kg. Small angle X-ray scattering (SAXS) of fluid gels revealed a progressive increase in gel network connectivity up to the calcium concentration where the peak in rheological properties was observed followed by a less interconnected network at calcium concentrations above the peak. Furthermore, rheological measurements supplemented with free calcium and zeta-potential measurements, support that the decrease after the peak in rheological response is due to the combination of fluid gel particle softening with a decrease in surface charge. The results of this study enable to establish clearer links between rheological behavior, particle properties and supramolecular structure of calcium-induced LAGG fluid gels. This work enables a more effective design of fluid gel properties for different applications from food to pharma and biomaterials.

PMID 42285681
阅读全文 →
PubMedJournal of biomedical materials research. Part B, Applied biomaterials2026-06-13

Highly Porous Carbonate Apatite Scaffolds Fabricated via Freeze-Drying for Accelerated Bone Replacement.

Taleb Alashkar Ahmad Nazir AN, Hayashi Koichiro K, Ishikawa Kunio K

Bone scaffolds should ideally possess good osteoconductivity and biodegradability, form abundant bone at an early stage, maintain the regenerated bone tissue, and be completely replaced by newly formed bone. Therefore, highly porous scaffolds composed of resorbable bioactive ceramics are promising candidates for bone repair. However, the methods for fabricating such scaffolds remain underdeveloped, and the in vivo efficacies of the generated structures have not been sufficiently evaluated. Therefore, the aims of this study were to develop a novel method for fabricating a highly porous carbonate apatite (CA) scaffold via a freeze-drying technique and to evaluate its structural, chemical, mechanical, and in vivo performance using a rabbit model of femoral condyle defect. The CA scaffold structure consisted of three-dimensionally interconnected pores, exhibiting high porosity (91.7%). Despite its high porosity, the scaffold did not collapse during implantation into the bone defect and was easy to handle. When implanted into critically sized bone defects, the CA scaffolds formed three times more new bone than that formed by clinically used CA granules after 4 weeks, with the bone area percentages in the CA scaffold, CA granule, and sham groups being 51.7% ± 8.1%, 14.0% ± 4.9%, and 1.2% ± 0.4%, respectively. After 12 weeks, the CA scaffolds maintained approximately three times the bone area of that formed by the CA granules and were almost completely replaced by newly formed bone. These findings indicate that the highly interconnected porous CA scaffold can achieve rapid bone regeneration and dynamically adjust its structure to accommodate newly formed bone, making it a promising candidate for bone regeneration applications.

PMID 42286853
阅读全文 →
PubMedJournal of cardiovascular computed tomography2026-06-13

Reinventing the coronary calcium scan.

Arbab-Zadeh Armin A

PMID 42285683
阅读全文 →
PubMedChinese journal of natural medicines2026-06-13

Pinoresinol diglucoside from Eucommia ulmoides attenuates diabetic cardiomyopathy through suppressing the store-operated calcium entry and downregulating the STIM1/Orai1/NFAT3 signaling pathway.

Feng Yujie Y, Mao Yanan Y, Li Junshuai J, Sun Zhipeng Z et al.

Pinoresinol diglucoside (PDG), an active component derived from Eucommia ulmoides, exhibits therapeutic effects against apoptosis, inflammation, and hypertrophy, etc. However, whether PDG plays a protective role in diabetic cardiomyopathy (DCM) is not fully elucidated. This study aimed to investigate the role and potential mechanism of PDG in DCM. The possible mechanism of PDG targeting DCM was identified by network pharmacology, bioinformatics, machine learning and molecular docking methods. The heart function of mice was evaluated using echocardiography. The pathological changes in the heart of mice were detected using H&E staining. Changes of Ca2+ fluorescence intensity values in H9c2 cells were assessed by confocal microscopy. Apoptosis was evaluated by TUNEL staining and flow cytometry. The expression of DCM-related genes and proteins, both in vivo and in vitro, was examined by qRT-PCR and Western blot. The results showed that PDG effectively improved the cardiac function and suppressed cardiac hypertrophy, inflammation, and cardiomyocyte apoptosis caused by DCM. Intriguingly, molecular docking results revealed that the therapeutic effect of PDG on DCM was associated with stromal interaction molecule 1 (STIM1), calcium release-activated calcium channel protein 1 (Orai1), and nuclear factor of activated T-cells 3 (NFAT3) signaling. Consistently, animal experiments results indicated that PDG significantly downregulated the expression of STIM1, Orai1, NFAT3 at the protein level, as well as the associated store-operated calcium entry (SOCE). Therefore, our findings revealed that PDG can alleviate cardiac hypertrophy, inflammation and apoptosis in DCM by downregulating the STIM1, Orai1, and NFAT3 signaling molecules. Thus, PDG may be a promising therapeutic candidate for treating DCM.

PMID 42285689
阅读全文 →
PubMedSeminars in arthritis and rheumatism2026-06-13

The OMERACT core domain sets for calcium pyrophosphate deposition disease.

Dalbeth Nicola N, Zhang Yiling Y, Hensey Owen O, Grossberg David D et al.

To develop OMERACT core domain sets for chronic and recurrent calcium pyrophosphate deposition (CPPD) disease and acute calcium pyrophosphate (CPP) crystal arthritis. Following OMERACT methodology, the CPPD Working Group (comprising of patient research partners, fellows, clinicians, and methodologists) defined the core domain sets. The development of the core sets occurred through a scoping review, qualitative study, Delphi surveys, and ranking exercises to identify the most relevant domains. A virtual e-module was developed to enable members of the OMERACT community to discuss and vote for endorsement of the OMERACT CPPD core domain sets. The core domains for chronic and recurrent CPPD are pain intensity, joint tenderness, joint swelling, acute CPP crystal arthritis flares, overall function, patient global assessment of disease activity, physician global assessment of disease activity, and adverse events including death. In voting, this core domain set was endorsed by 14/14 (100%) patient research partners and 85/87 (98%) other participants. The core domains for acute CPP crystal arthritis are pain intensity, joint tenderness, joint swelling, duration of acute CPP crystal arthritis flare, overall function, patient global assessment of disease activity, and adverse events including death. In voting, this core domain set was endorsed by 14/14 (100%) patient research partners and 83/86 (97%) other participants. Definitions for all core domains have been developed. These core domains provide a foundation for future clinical trials and longitudinal studies in CPPD by defining the minimum outcomes that should be assessed and reported to ensure relevance and comparability across studies.

PMID 42284818
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多calcium carbonate